Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma
Authors:
- 5 February 2024
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 281 (4) , 1971-1989
Abstract
Objective To determine the predictive value of the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), neutrophil-to-eosinophil ratio (NER), lymphocyte-to-eosinophil ratio (LER), monocyte-to-eosinophil ratio (MER), systemic inflammatory response index (SIRI), and ratio of inflammatory cells before and after treatment for predicting survival in advanced nasopharyngeal carcinoma (NPC) and to provide a reference for treatment. Methods A retrospective review of 70 patients was performed. Serological indexes were obtained by drawing blood before and after systemic therapy. The cutoff values of these indexes were determined by receiver operating characteristic (ROC) curves. The prognostic value of the indexes for overall survival (OS) and distant metastasis free survival (DMFS) was evaluated. Results Survival analysis showed that a smaller pretreatment LMR value was associated with poor OS; larger pretreatment NER, LER, MER, and SIRI values were associated with poor OS; a smaller posttreatment LMR value was associated with poor OS; larger posttreatment NLR, NER, MER, and SIRI values were associated with poor OS; a smaller pretreatment LMR value was associated with poor DMFS; larger pretreatment NLR, NER, LER, and MER values were associated with poor DMFS; and larger posttreatment NLR, NER, LER, and MER values were associated with poor DMFS. Furthermore, a larger neutrophil after treatment-to-neutrophil before treatment ratio was associated with poor OS and DMFS. Logistic regression analysis showed that pretreatment MER and posttreatment NLR were independent predictors of OS in patients with advanced NPC; moreover, pretreatment and posttreatment MER and NLR were independent prognostic factors for DMFS in patients with advanced NPC. Conclusions The NLR, NER and MER can be used to predict survival in advanced NPC patients. Eosinophils might be one of the factors for the good prognosis of NPC patients. In addition, an increased number of neutrophils after treatment may indicate a favorable prognosis.Keywords
Funding Information
- Natural Science Foundations of Hunan Province, China (2021JJ40913)
This publication has 42 references indexed in Scilit:
- Tumor associated macrophages and neutrophils in tumor progressionJournal of Cellular Physiology, 2013
- Neutrophil extracellular trapsOncoImmunology, 2013
- Eosinophils: changing perspectives in health and diseaseNature Reviews Immunology, 2012
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionScience, 2011
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigmNature Immunology, 2010
- Cytokines as a key component of cancer-related inflammationCytokine, 2008
- Cancer-related inflammationNature, 2008
- THE EOSINOPHILAnnual Review of Immunology, 2006
- Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinomaJournal of Clinical Pathology, 2004
- Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancerCancer, 1983